GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Galaxy Surfactants Ltd

Galaxy Surfactants: Q4 FY26 Total Revenue Rs. 1,315.0 cr, FY26 Revenue Rs. 5,270.4 cr

RESULTS ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 14 May 2026, 08:49 PM IST  ·  BSE ID: 69421cb5-a8c6-43f1-b050-1ce04490afba
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's revenue increased significantly for the full year, but quarterly and annual profits saw a decline.
🤖 AI Summary
  • Galaxy Surfactants reported consolidated Total Revenue of Rs. 1,315.0 cr for Q4 FY26.
  • Full-year FY26 consolidated Total Revenue reached Rs. 5,270.4 cr, marking a 24.0% YoY increase.
  • Q4 FY26 consolidated PAT was Rs. 62.4 cr, representing a 17.7% decline YoY.
  • FY26 consolidated PAT decreased by 12.3% to Rs. 267.4 cr, including Rs 11.9 cr statutory impact.
  • Overall volumes remained flat in Q4 FY26 and FY26, with India volumes growing high single-digit in Q4.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Q4FY26 Total Revenue
₹ 1,315.0 cr
14.1%
Q4FY26 EBITDA
₹ 121.9 cr
-9.5%
Q4FY26 PAT
₹ 62.4 cr
-17.7%
FY26 Total Revenue
₹ 5,270.4 cr
24.0%
FY26 EBITDA
₹ 497.4 cr
-2.5%
FY26 PAT
₹ 267.4 cr
-12.3%
Q4FY26 EBITDA Margin
9.3%
FY26 EBITDA Margin
9.4%
🏢 How This Affects the Company
📈
Business Impact
Consolidated Total Revenue increased by 24.0% for FY26 to Rs. 5,270.4 cr, indicating higher sales realization or volume growth. Specialty Care products showed high single-digit volume growth in Q4 FY26 and FY26.
💰
Financial Impact
Consolidated PAT decreased by 12.3% for FY26 to Rs. 267.4 cr, and by 17.7% for Q4 FY26 to Rs. 62.4 cr. EBITDA margin for Q4 FY26 was 9.3%, down from 11.7% in Q4 FY25, impacting profitability.
⚙️
Operational Impact
AMET region volumes saw a mid-teens YoY decline in Q4 FY26 due to logistics disruptions, raw material constraints, and geopolitical uncertainty. Overall volumes remained flat in Q4 FY26 and FY26.
⚠️
Risk Impact
The ongoing West Asia conflict impacted global supply chains, logistics, and input costs, posing near-term operational and cost challenges for the company.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any immediate action based on this financial results press release.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, specifically the decline in consolidated PAT for both Q4 and the full year FY26.
🔍
Management Signal
Management indicates a focus on agile pricing actions, strong customer partnerships, and continued specialty growth to navigate a disrupted operating environment.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q1 FY27 results — check for sequential improvement in profitability and margins.
Updates on West Asia conflict — assess impact on global supply chains and logistics.
Future investor calls — monitor management commentary on cost pass-through and specialty growth.
MEDIUM RISK Geopolitical uncertainties impacting global supply chains and input costs pose ongoing operational and profitability risks.
💡 Investor Takeaway
Galaxy Surfactants reported Q4 FY26 consolidated Total Revenue of Rs. 1,315.0 cr, up 14.1% YoY, but PAT declined 17.7% to Rs. 62.4 cr. For FY26, Total Revenue grew 24.0% to Rs. 5,270.4 cr, while PAT decreased 12.3% to Rs. 267.4 cr.
⚖️ Strengths & Concerns

✅ Positives

  • Total Revenue for FY26 increased by 24.0% to Rs. 5,270.4 cr, demonstrating growth in top-line performance.
  • India region reported high single-digit volume growth in Q4 FY26, led by Specialty Care Products, showing domestic market resilience.

⚠️ Concerns

  • Consolidated PAT declined by 12.3% in FY26 to Rs. 267.4 cr and by 17.7% in Q4 FY26 to Rs. 62.4 cr.
  • EBITDA margin reduced from 11.7% in Q4 FY25 to 9.3% in Q4 FY26, indicating lower operational profitability.
📅 Company Track Record
Galaxy Surfactants' previous filing on May 14, 2026, reported FY26 consolidated income of Rs. 3,618.70 Crore and recommended a Rs. 22/- dividend. Another filing on the same date indicated FY26 revenue at Rs. 3,589.07 Crore. The current press release provides updated consolidated figures, with FY26 Total Revenue at Rs. 5,270.4 cr.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.